Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed director
|
|
Eidos Therapeutics, Inc. (EIDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/13/2018 |
4/A
| BridgeBio Pharma LLC (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Bought 37,989 shares
@ $13.29, valued at
$504.9k
Bought 2,664 shares
@ $13.96, valued at
$37.2k
|
|
| 12/13/2018 |
4/A
| BridgeBio Pharma LLC (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Bought 38,970 shares
@ $13.34, valued at
$519.9k
Bought 36,314 shares
@ $13.94, valued at
$506.2k
Bought 4,860 shares
@ $14.36, valued at
$69.8k
|
|
|
|